Highlights
ASX: CSL       CSL LIMITED
Last Price Today's Change   Day's Range   Trading Volume
301.72   +5.08 (1.71%)  294.15 - 304.20  674,189

Overview

 
Avg Volume (4 weeks):634,031
4 Weeks Range:271.77 - 304.20
4 Weeks Price Volatility (%):
92.35%
52 Weeks Range:242.00 - 320.42
52 Weeks Price Volatility (%):
76.15%
Average Price Target: 88.00
Price Target Upside/Downside: -213.72

Headlines



No recent Headlines for this stock.


Business Background

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

634  978  647  1738 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CE1 0.008-0.001 
 GED 0.014+0.002 
 CYQ 0.002+0.001 
 AUZ 0.028+0.004 
 PDN 0.505-0.07 
 MTH 0.018+0.003 
 DDD 0.0050.00 
 ISD 0.16+0.092 
 PAB 0.041+0.007 
 AO1 0.007-0.001